Studies are key

Effective and safe products – this is the standard that we measure ourselves by.
For this reason, we carry out comprehensive clinical development programmes to provide objective evidence that our products are effective and well-tolerated. In the last year alone, about 1.200 patients were attended to in our clinical studies.

We – employees in Cambridge and Limburg – are committed to this complex assignment of carrying out responsible clinical research across different therapeutic areas from phase I through to phase IV . Our work is diverse, interesting – and challenging. Both for the team and for the individual.

Why so? Our field of activity has many aspects. It covers the initial planning of the studies in terms of their medical & scientific content, their implementation and the evaluation and reporting of the collected data. In addition to this we are specialists in clinical research with opioids – an area that can prove even more challenging. To achieve the best results, we don't just work on our own. We have close connections to other departments in our company, key opinion leaders and contract research organisations (CROs).

Organisation is everything!

We carry out the studies in cooperation with specialist units, Investigators and CROs – We oversee all aspects from selecting investigator sites, through patient recruitment, the collection of data to the final completion of patient recruitment. Our work also comprises the development of clinical study reports, manuscripts, abstracts and posters.

Results count!

All the study data is checked and validated by us, evaluated and summarised in a study report which can be used by regulatory authorities, the medical community and the public to see the results of our clinical studies.

print page

Our service portfolio is very diverse and includes: clinical study design, study management, monitoring of studies, data review and medical writing – across phase I to IV and throughout Europe and other regions of the world.